OBJECTIVES: Lumen-apposing metal stents (LAMSs) are increasingly used for direct endoscopic necrosectomy (DEN) in the management of walled-off necrosis (WON). We compared LAMS and traditional cystoenterostomy in the management of WON. METHODS: Retrospective analysis of patients who underwent DEN for management of WON was performed. Primary outcome was rate of WON resolution. Secondary outcomes included technical and clinical success, time and number of procedures until resolution, requirement for alternative therapy, recurrence, and adverse events. RESULTS: One hundred twelve patients underwent DEN with LAMS (n = 34) or traditional cystoenterostomy (n = 78). Mean WON size was 90.2 × 60.1 mm, and 61.8% had infected necrosis. Overall WON resolution was similar between LAMS and traditional cystoenterostomy (94.1% vs 92.1%, P = 0.510), with similar number of procedures until resolution (1.5 vs 1.5, P = 0.871). The LAMSs were associated with faster resolution (86.9 vs 133.6 days, P = 0.038), lower recurrence (6.3% vs 23.1%, P = 0.032), and decreased requirement for surgery (0% vs 12.8%, P = 0.031) compared with traditional cystoenterostomy, but higher adverse event rates (41.2% vs 7.7%, P < 0.001). CONCLUSIONS: Despite higher adverse event rates, initial LAMS cystoenterostomy for management of WON results in faster resolution, lower recurrence, and decreased requirement for surgery.
OBJECTIVES: Lumen-apposing metal stents (LAMSs) are increasingly used for direct endoscopic necrosectomy (DEN) in the management of walled-off necrosis (WON). We compared LAMS and traditional cystoenterostomy in the management of WON. METHODS: Retrospective analysis of patients who underwent DEN for management of WON was performed. Primary outcome was rate of WON resolution. Secondary outcomes included technical and clinical success, time and number of procedures until resolution, requirement for alternative therapy, recurrence, and adverse events. RESULTS: One hundred twelve patients underwent DEN with LAMS (n = 34) or traditional cystoenterostomy (n = 78). Mean WON size was 90.2 × 60.1 mm, and 61.8% had infected necrosis. Overall WON resolution was similar between LAMS and traditional cystoenterostomy (94.1% vs 92.1%, P = 0.510), with similar number of procedures until resolution (1.5 vs 1.5, P = 0.871). The LAMSs were associated with faster resolution (86.9 vs 133.6 days, P = 0.038), lower recurrence (6.3% vs 23.1%, P = 0.032), and decreased requirement for surgery (0% vs 12.8%, P = 0.031) compared with traditional cystoenterostomy, but higher adverse event rates (41.2% vs 7.7%, P < 0.001). CONCLUSIONS: Despite higher adverse event rates, initial LAMS cystoenterostomy for management of WON results in faster resolution, lower recurrence, and decreased requirement for surgery.
Authors: Michael Gluck; Andrew Ross; Shayan Irani; Otto Lin; Ellen Hauptmann; Justin Siegal; Mehran Fotoohi; Robert Crane; David Robinson; Richard A Kozarek Journal: Clin Gastroenterol Hepatol Date: 2010-09-24 Impact factor: 11.382
Authors: Ali A Siddiqui; Douglas G Adler; Jose Nieto; Janak N Shah; Kenneth F Binmoeller; Steve Kane; Linda Yan; Sobia N Laique; Thomas Kowalski; David E Loren; Linda Jo Taylor; Satish Munigala; Yasser M Bhat Journal: Gastrointest Endosc Date: 2015-10-26 Impact factor: 9.427
Authors: Raj J Shah; Janak N Shah; Irving Waxman; Thomas E Kowalski; Andres Sanchez-Yague; Jose Nieto; Brian C Brauer; Monica Gaidhane; Michel Kahaleh Journal: Clin Gastroenterol Hepatol Date: 2014-10-05 Impact factor: 11.382
Authors: Olaf J Bakker; Hjalmar C van Santvoort; Sandra van Brunschot; Ronald B Geskus; Marc G Besselink; Thomas L Bollen; Casper H van Eijck; Paul Fockens; Eric J Hazebroek; Rian M Nijmeijer; Jan-Werner Poley; Bert van Ramshorst; Frank P Vleggaar; Marja A Boermeester; Hein G Gooszen; Bas L Weusten; Robin Timmer Journal: JAMA Date: 2012-03-14 Impact factor: 56.272
Authors: Hjalmar C van Santvoort; Marc G Besselink; Olaf J Bakker; H Sijbrand Hofker; Marja A Boermeester; Cornelis H Dejong; Harry van Goor; Alexander F Schaapherder; Casper H van Eijck; Thomas L Bollen; Bert van Ramshorst; Vincent B Nieuwenhuijs; Robin Timmer; Johan S Laméris; Philip M Kruyt; Eric R Manusama; Erwin van der Harst; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Maarten S van Leeuwen; Erik Buskens; Hein G Gooszen Journal: N Engl J Med Date: 2010-04-22 Impact factor: 91.245
Authors: Emanuele Rinninella; Rastislav Kunda; Markus Dollhopf; Andres Sanchez-Yague; Uwe Will; Ilaria Tarantino; Joan Gornals Soler; Sebastian Ullrich; Alexander Meining; Josè Miguel Esteban; Thomas Enz; Geoffroy Vanbiervliet; Frank Vleggaar; Fabia Attili; Alberto Larghi Journal: Gastrointest Endosc Date: 2015-05-23 Impact factor: 9.427
Authors: Reem Z Sharaiha; Amy Tyberg; Mouen A Khashab; Nikhil A Kumta; Kunal Karia; Jose Nieto; Uzma D Siddiqui; Irving Waxman; Virendra Joshi; Petros C Benias; Peter Darwin; Christopher J DiMaio; Christopher J Mulder; Shai Friedland; David G Forcione; Divyesh V Sejpal; Tamas A Gonda; Frank G Gress; Monica Gaidhane; Ann Koons; Ersilia M DeFilippis; Sanjay Salgado; Kristen R Weaver; John M Poneros; Amrita Sethi; Sammy Ho; Vivek Kumbhari; Vikesh K Singh; Alan H Tieu; Viviana Parra; Alisa Likhitsup; Craig Womeldorph; Brenna Casey; Sreeni S Jonnalagadda; Amit P Desai; David L Carr-Locke; Michel Kahaleh; Ali A Siddiqui Journal: Clin Gastroenterol Hepatol Date: 2016-05-14 Impact factor: 11.382
Authors: Jayant P Talreja; Vanessa M Shami; Jennifer Ku; Tanya D Morris; Kristi Ellen; Michel Kahaleh Journal: Gastrointest Endosc Date: 2008-12 Impact factor: 9.427
Authors: Viktoria Hentschel; Benjamin Walter; Noemi Harder; Frank Arnold; Thomas Seufferlein; Martin Wagner; Martin Müller; Alexander Kleger Journal: Antibiotics (Basel) Date: 2022-03-21